SeaBridge Investment Advisors LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
SeaBridge Investment Advisors LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$6,0000.0%3000.0%0.00%0.0%
Q2 2020$6,000
+50.0%
3000.0%0.00%0.0%
Q1 2020$4,0000.0%3000.0%0.00%
+100.0%
Q4 2019$4,0000.0%3000.0%0.00%0.0%
Q3 2019$4,000
-20.0%
3000.0%0.00%
-50.0%
Q2 2019$5,0000.0%3000.0%0.00%0.0%
Q1 2019$5,000
+25.0%
3000.0%0.00%
+100.0%
Q4 2018$4,000
-55.6%
3000.0%0.00%
-50.0%
Q3 2018$9,000
+12.5%
3000.0%0.00%0.0%
Q2 2018$8,000
+33.3%
3000.0%0.00%
+100.0%
Q1 2018$6,0003000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders